112 related articles for article (PubMed ID: 30833045)
1. [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence].
Cowppli-Bony A; Colonna M; Ligier K; Jooste V; Defossez G; Monnereau A; ;
Bull Cancer; 2019; 106(7-8):617-634. PubMed ID: 30833045
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012.
Colonna M; Danzon A; Delafosse P; Mitton N; Bara S; Bouvier AM; Ganry O; Guizard AV; Launoy G; Molinie F; Sauleau EA; Schvartz C; Velten M; Grosclaude P; Tretarre B
Eur J Cancer; 2008 Jan; 44(1):115-22. PubMed ID: 18032021
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence and mortality in France over the period 1978-2000.
Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
[TBL] [Abstract][Full Text] [Related]
6. Time trends and short term projections of cancer prevalence in France.
Colonna M; Boussari O; Cowppli-Bony A; Delafosse P; Romain G; Grosclaude P; Jooste V;
Cancer Epidemiol; 2018 Oct; 56():97-105. PubMed ID: 30125884
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--report 2006: 1. Incidence, mortality and estimates.
AIRT Working Group
Epidemiol Prev; 2006; 30(1 Suppl 2):8-10, 12-28, 30-101 passim. PubMed ID: 16826725
[TBL] [Abstract][Full Text] [Related]
8. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
9. [Cancers: incidence and survival in metropolitan France].
De Brauer C; Bousquet PJ; Lafay L
Rev Prat; 2024 Jan; 74(1):30-35. PubMed ID: 38329248
[TBL] [Abstract][Full Text] [Related]
10. Incidence of prostate cancer and net survival by grade in a geriatric population: A population-based study in a French administrative entity from 1991 to 2013.
Bellier A; Colonna M; Delafosse P; Seigneurin A
Cancer Epidemiol; 2018 Oct; 56():60-66. PubMed ID: 30048940
[TBL] [Abstract][Full Text] [Related]
11. Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.
Binder-Foucard F; Bossard N; Delafosse P; Belot A; Woronoff AS; Remontet L;
Rev Epidemiol Sante Publique; 2014 Apr; 62(2):95-108. PubMed ID: 24613140
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of rare cancers and inequalities in oncologic outcomes.
Gatta G; Trama A; Capocaccia R;
Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
[TBL] [Abstract][Full Text] [Related]
13. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
14. Unbiased estimates of long-term net survival of solid cancers in France.
Jooste V; Grosclaude P; Remontet L; Launoy G; Baldi I; Molinié F; Arveux P; Bossard N; Bouvier AM; Colonna M;
Int J Cancer; 2013 May; 132(10):2370-7. PubMed ID: 23001495
[TBL] [Abstract][Full Text] [Related]
15. Estimates of cancer incidence and mortality in Europe in 1995.
Bray F; Sankila R; Ferlay J; Parkin DM
Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.
Colonna M; Bossard N; Guizard AV; Remontet L; Grosclaude P;
Ann Endocrinol (Paris); 2010 Mar; 71(2):95-101. PubMed ID: 20036351
[TBL] [Abstract][Full Text] [Related]
17. [Incidence and prevalence estimations for breast and colorectal cancer in the Picardy region].
Peng J; Ganry O; Tramier B; Dubreuil A; Raverdy N; Thulliez A;
Rev Epidemiol Sante Publique; 2002 Oct; 50(5):427-32. PubMed ID: 12471335
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
[TBL] [Abstract][Full Text] [Related]
19. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.
India State-Level Disease Burden Initiative Cancer Collaborators
Lancet Oncol; 2018 Oct; 19(10):1289-1306. PubMed ID: 30219626
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
